Evidence map›Paper›PMID 9693360›Full record

ArticleMolecular biology of the cell1998

Integrin-mediated signaling events in human endothelial cells.

S M Short, G A Talbott, R L Juliano

Abstract read
In one paragraph

Article in Molecular biology of the cell, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 162 citations in OpenAlex.

  1. Article
  2. Anoikis: To Die or Not to Die?International journal of molecular sciences · 2026
    Review
  3. Article
  4. The endothelium at the interface between tissues andClinical microbiology reviews · 2025
    Review
  5. Impact of Exercise Intensity on Cerebral BDNF Levels: Role of FNDC5/Irisin.International journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Subendothelial matrix components influence endothelial cell apoptosis in vitro.American journal of physiology. Cell physiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S M ShortDepartment of Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
G A Talbott
R L Juliano
University of North Carolina at Chapel Hill · US

Funding

THE ROLE OF RAP1 IN INTEGRIN ACTIVATION AND PLATELET SIGNALINGP01HL045100 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PARISE, LESLIE V. · 1993 to 2007
$13.7M
MOLECULAR BASES OF CELL ADHESIONR01GM026165 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JULIANO, RUDOLPH · 1985 to 2003
$1.0M
NHLBI NIH HHS NHLBI-45100NIGMS NIH HHS GM-26165NIGMS NIH HHS R01 GM026165
6 · The paper itself

Abstract

Vascular endothelial cells are important in a variety of physiological and pathophysiological processes. The growth and functions of vascular endothelial cells are regulated both by soluble mitogenic and differentiation factors and by interactions with the extracellular matrix; however, relatively little is known about the role of the matrix. In the present study, we investigate whether integrin-mediated anchorage to a substratum coated with the extracellular matrix protein fibronectin regulates growth factor signaling events in human endothelial cells. We show that cell adhesion to fibronectin and growth factor stimulation trigger distinct initial tyrosine phosphorylation events in endothelial cells. Thus, integrin-dependent adhesion of endothelial cells leads to tyrosine phosphorylation of both focal adhesion kinase and paxillin, but not of several growth factor receptors. Conversely, EGF stimulation causes receptor autophosphorylation, with no effect on focal adhesion kinase or paxillin tyrosine phosphorylation. Adhesion to fibronectin, in the absence of growth factors, leads to activation of MAPK. In addition, adhesion to fibronectin also potentiates growth factor signaling to MAPK. Thus, polypeptide growth factor activation of MAPK in anchored cells is far more effective than in cells maintained in suspension. Other agonists known to activate MAPK were also examined for their ability to activate MAPK in an anchorage-dependent manner. The neuropeptide bombesin, the bioactive lipid lysophosphatidic acid (LPA), and the cytokine tumor necrosis factor alpha, which signal through diverse mechanisms, were all able to activate MAPK to a much greater degree in fibronectin-adherent cells than in suspended cells. In addition, tumor necrosis factor alpha activation of c-Jun kinase (JNK) was also much more robust in anchored cells. Together, these data suggest a cooperation between integrins and soluble mitogens in efficient propagation of signals to downstream kinases. This cooperation may contribute to anchorage dependence of mitogenic cell cycle progression.

Indexed as

Mitogen-Activated Protein KinasesBombesinCalcium-Calmodulin-Dependent Protein KinasesCell AdhesionCell Adhesion MoleculesCell CycleCells, CulturedCytoskeletal ProteinsEndothelium, VascularEpidermal Growth FactorErbB ReceptorsFibronectinsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGrowth SubstancesHumansBombesinCalcium-Calmodulin-Dependent Protein KinasesCell Adhesion MoleculesCytoskeletal ProteinsEpidermal Growth FactorErbB ReceptorsFibronectinsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGrowth SubstancesIntegrinsJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein KinasesPaxillinPhosphoproteinsProtein-Tyrosine KinasesPTK2 protein, humanPXN protein, human

Identifiers

PMID9693360
PMCPMC25448
OpenAlexW2168955823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.